Press Release

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Asia Pacific In-vitro Diagnostics Market to Grow at a CAGR of 5.2% During the Period 2022-2027, Driven by Need for Effective and Efficient Detection Technologies

According to a new report by EMR titled, ‘Asia Pacific In-vitro Diagnostics Market Report and Forecast 2022-2027’, the Asia Pacific In-vitro Diagnostics market is expected to grow at a CAGR of 5.2% during the period 2022-2027, led by advancements in technology.

Asia Pacific in-vitro diagnostics market is expected to be driven by the need to be prepared for health pandemics, spread of chronic diseases, ageing demographic, rising income levels, technological advancements, and increasing demand for quality medical care. In-vitro diagnostics (IVD) refer to tests carried out on samples such as blood or tissue those taken from the human body. In vitro diagnostics can detect diseases, infections, or other conditions, and may be used to monitor a person’s overall health to help treat, cure, or prevent illnesses.

In the Indian in-vitro diagnostics industry, many positive trends are being witnessed. Producers of IVD devices have kept pace with rising demand for testing volumes with innovative diagnostic solutions driving industry growth. Advanced diagnostic technologies like molecular and Nex-Gen Sequencing are experiencing fast-paced growth. Leading companies are investing in research for the development of new technologies for infectious diseases such as TB, HIV, Hepatitis, etc. Point-of-care testing (POCT) is becoming increasingly popular in resource-limited settings. Producers are expanding their product portfolio to include POCT solutions for conditions including diabetes, pregnancy tests, testing for infections like Transfusion transmitted infections (TTIs), malaria, dengue, COVID-19, and others. Such developments are likely to boost the Asia Pacific in-vitro diagnostics market. Increasing efficiency of after-sales services in Tier II, III and IV cities of India has also been a key factor behind market growth.

Automation is playing a vital role in market expansion. As demand for tests increases, labs seek new ways to handle the great workload. Solution providers are engaged in developing solutions capable of meeting rising demand for quality, speed, affordability and precision. Labs today are more inclined to switch from semi to fully automated equipment. Further, integration of automated systems with Internet of things (IoT) is aiding producers in offering the advantage of 24x7 remote access, predictive maintenance and inventory management. Artificial intelligence (AI) based diagnostic devices are improving lab workflow efficiency by enabling a shorter turnaround time (TAT) and testing of more samples. These factors are expected to drive the Asia Pacific in-vitro diagnostics market.

Leading companies are engaged in developing solutions enabling efficient and accurate detection of illnesses. Key players in the domain include Sysmex Corporation, Medical & Biological Laboratories Co., Ltd., Voxtur Bio Ltd., Immulab, FUJIFILM Corporation, and Others.

Key Findings of the Report:

  • The Asia Pacific in-vitro diagnostics market is expected to be driven by the need for effective and efficient detection technologies.   
  • Advanced solutions are expected to boost market growth.
  • Advancements in technology are expected to stimulate market growth.

Market Analysis by Product and Service, Technology, Application, End Use, and Country:

  • By product and service, the market is segmented into Reagents and Kits, Instruments, and Software and Services.
  • By technology, the market is classified into Immunoassay/Immunochemistry, Clinical Chemistry, Molecular Diagnostics, Haematology, Microbiology, Blood Glucose Self-Monitoring, Coagulation and Haemostasis, Urinalysis, and Others.
  • By application, the market is divided into Infectious Diseases, Diabetes, Cardiology, Oncology, Autoimmune Diseases, Nephrology, and Others.
  • By end use, the market is segmented into Hospitals, Laboratories, Homecare, and Others.
  • By country, the market is classified into China, Japan, India, ASEAN, Australia, and Others.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us:

Expert Market Research
Website:
www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER